Suchergebnisse - "Signal transduction inhibitors"

PubPharm (57)

1

Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53

enthalten in: Advances in biological regulation | 2021

von Abrams, S. | Akula, S. | Martelli, A. | +10

2

Overview of New Treatments with Immunotherapy for Breast Cancer and a Proposal of a Combination Therapy

enthalten in: Molecules (Basel, Switzerland) | 2020

von Galván Morales, M. | Barrera Rodríguez, R. | Santiago Cruz, J. | +1

3

Insights on the Interplay between Cells Metabolism and Signaling : A Therapeutic Perspective in Pediatric Acute Leukemias

enthalten in: International journal of molecular sciences | 2020

von Anselmi, L. | Bertuccio, S. | Lonetti, A. | +3

4

Folate decorated polymeric micelles for targeted delivery of the kinase inhibitor dactolisib to cancer cells

enthalten in: International journal of pharmaceutics | 2020

von Shi, H. | van Steenbergen, M. | Lou, B. | +3

5

Overview of New Treatments with Immunotherapy for Breast Cancer and a Proposal of a Combination Therapy

in: Molecules | 2020

von Miguel Angel Galván Morales | Raúl Barrera Rodríguez | Julio Raúl Santiago Cruz | +1

6

Insights on the Interplay between Cells Metabolism and Signaling: A Therapeutic Perspective in Pediatric Acute Leukemias

in: International Journal of Molecular Sciences | 2020

von Laura Anselmi | Salvatore Nicola Bertuccio | Annalisa Lonetti | +3

7

RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma

enthalten in: Expert opinion on therapeutic targets | 2019

von Akula, S. | Abrams, S. | Steelman, L. | +7

8

Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells

enthalten in: Advances in biological regulation | 2019

von Akula, S. | Candido, S. | Libra, M. | +19

9

Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells

enthalten in: Advances in biological regulation | 2019

von Abrams, S. | Follo, M. | Steelman, L. | +15

10

A phase I trial to determine safety and pharmacokinetics of ASLAN002, an oral MET superfamily kinase inhibitor, in patients with advanced or metastatic solid cancers

enthalten in: Investigational new drugs | 2018

von Roohullah, A. | Cooper, A. | Lomax, A. | +9

1
2
3
4
5
6
Nächster »
[6]